Eisbach Bio GmbH
PrivateLast Round
Grant
Nov 26, 2024
Total Funding Raised
$22.02M
Company Overview
Eisbach Bio GmbH operates in Healthcare & Life Sciences and is based in Planegg. Its latest recorded funding round was a Grant round in November 2024.
Eisbach Bio GmbH is a biotechnology company that develops novel drugs targeting molecular vulnerabilities in cancer genomes using its proprietary allosteric platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eisbach Bio GmbH Comparables
Compare Eisbach Bio GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MOMA Therapeutics | 83% | |
| STORM Therapeutics | 79% | |
| Breakpoint Therapeutics | 77% |
For institutional investors. Book with your work email.
Eisbach Bio GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 26, 2024 | ||||
| VC Round | Mar 21, 2024 | ||||
| Grant | Nov 3, 2021 | ||||
| Grant | Jul 7, 2021 | ||||
| Accelerator | Jun 26, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Eisbach Bio GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bundesministerium für Bildung und Forschung | Grant |
| EIT Health | Accelerator |
| The University of Texas MD Anderson Cancer Center | VC Round |
| Cancer Focus Fund | VC Round |
| Bavarian State Ministry of Economic Affairs, Regional Development and Energy | Grant |
| Cancer Prevention and Research Institute of Texas | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors grew 69% MoM, from 727 to 1.2K.
- May 19, 2026
Monthly visitors grew 78% MoM.
For institutional investors. Book with your work email.
Eisbach Bio GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Eisbach Bio GmbH's valuation, stock price, and market status.
Is Eisbach Bio GmbH a public or private company?
Eisbach Bio GmbH is a private company.
What is the current stock price of Eisbach Bio GmbH?
Eisbach Bio GmbH is a private company, so its shares have no public market price. Caplight tracks Eisbach Bio GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Eisbach Bio GmbH worth (valuation)?
Valuation information for Eisbach Bio GmbH is not publicly available.
Can I buy Eisbach Bio GmbH stock?
Eisbach Bio GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Eisbach Bio GmbH's last funding round?
Eisbach Bio GmbH's most recent funding round was Grant on November 26, 2024.
Who are the main investors in Eisbach Bio GmbH?
Key investors in Eisbach Bio GmbH include Cancer Focus Fund.
Will Eisbach Bio GmbH IPO soon?
No public IPO plans have been announced for Eisbach Bio GmbH.
How can I track Eisbach Bio GmbH secondary market activity?
Caplight tracks bids, offers, and trades in Eisbach Bio GmbH's shares on secondary markets.